Clinical Psychopharmacology and Neuroscience
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 60.1% | 0.976 | Q1 | 83.3% |
| 2024 | 2.7 | Q2 | 53.8% | 0.870 | Q2 | 80.4% |
| 2023 | 2.4 | Q3 | 48.0% | 0.802 | Q2 | 79.8% |
| 2022 | 3.2 | Q3 | 57.0% | 0.740 | Q2 | 78.4% |
| 2021 | 3.7 | Q2 | 63.8% | 0.835 | Q2 | 82.3% |
| 2020 | — | — | 0.770 | Q2 | 78.8% | |
| 2019 | — | — | 0.748 | Q2 | 78.6% | |
| 2018 | — | — | 0.891 | Q2 | 81.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1738-1088
ISSN
2093-4327
country
KRcoverage
2005-2026